Agnieszka Stelmaszyk[Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	2
2021	1
2024	0

Page 1

Did you mean agnieszka stelmasiak[Author] (1 results)?

Sirtuin 1 as the mechanism of action of agents used in the diabetes mellitus pharmacotherapy.

Stelmaszyk A, Mikołajczak P, Dworacka M. Stelmaszyk A, et al. Eur J Pharmacol. 2021 Sep 15;907:174289. doi: 10.1016/j.ejphar.2021.174289. Epub 2021 Jun 30. Eur J Pharmacol. 2021. PMID: 34214583 Review.

Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability.

Dworacka M, Iskakova S, Wesołowska A, Zharmakhanova G, Stelmaszyk A, Frycz BA, Jagodziński PP, Dworacki G. Dworacka M, et al. Among authors: stelmaszyk a. Diabetes Res Clin Pract. 2018 Sep;143:245-253. doi: 10.1016/j.diabres.2018.07.023. Epub 2018 Jul 26. Diabetes Res Clin Pract. 2018. PMID: 30056191

The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall.

Stelmaszyk A, Wesołowska A, Pomieczyńska K, Iskakova S, Frydrychowicz M, Dworacki G, Dworacka M. Stelmaszyk A, et al. Saudi Pharm J. 2018 Dec;26(8):1192-1198. doi: 10.1016/j.jsps.2018.07.008. Epub 2018 Jul 20. Saudi Pharm J. 2018. PMID: 30510471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year